Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiseptic Mouthwashes for SARS-CoV-2 Load Reduction
NCT04409873Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Mar 2021
- Primary completion
- Sep 2022
- Modality
- Conventional Liposomes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrogen peroxide, cetylpyridinium chloride, CloSYS Oral Rinse, Listerine Zero in coronavirus disease 2019 (COVID-19), sponsored by University of California, San Francisco. Started Mar 2021; status: terminated.
02
Drugs
hydrogen peroxidecetylpyridinium chlorideCloSYS Oral RinseListerine Zero
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04409873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04409873.